Literature DB >> 15915490

Tobacco use following liver transplantation for alcoholic liver disease: an underestimated problem.

Andrea DiMartini1, Lubna Javed, Sarah Russell, Mary Amanda Dew, Mary Grace Fitzgerald, Ashok Jain, John Fung.   

Abstract

Alcohol and tobacco use commonly co-occur, with at least 90% of those with an alcohol problem also using tobacco. Thus, 3 years ago when we discovered higher rate of late deaths due to lung and oropharyngeal cancer in patients who had received a transplant for alcoholic liver disease (ALD), we hypothesized that these patients were continuing to expose themselves to tobacco after liver transplantation (post-LTX) and that this behavior was increasing their risk for cancer. We subsequently began a prospective investigation of post-LTX tobacco use in patients having undergone LTX for ALD (n = 172). For 33 recipients we had data starting from our first assessment at 3 months post-LTX and for this subgroup we report on the details of the timing of tobacco use resumption and the redevelopment of nicotine addiction. We found that on average more than 40% are smoking across all time periods. ALD recipients resume smoking early post-LTX, increase their consumption over time, and quickly become tobacco dependent. These data highlight an underrecognized serious health risk for these patients and demonstrate our need for more stringent clinical monitoring and intervention for tobacco use in the pre- and post-LTX periods.

Entities:  

Mesh:

Year:  2005        PMID: 15915490     DOI: 10.1002/lt.20385

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  18 in total

Review 1.  Binge drinking: Burden of liver disease and beyond.

Authors:  Susana Llerena; María Teresa Arias-Loste; Angela Puente; Joaquín Cabezas; Javier Crespo; Emilio Fábrega
Journal:  World J Hepatol       Date:  2015-11-28

2.  Meta-analysis of risk for relapse to substance use after transplantation of the liver or other solid organs.

Authors:  Mary Amanda Dew; Andrea F DiMartini; Jennifer Steel; Annette De Vito Dabbs; Larissa Myaskovsky; Mark Unruh; Joel Greenhouse
Journal:  Liver Transpl       Date:  2008-02       Impact factor: 5.799

3.  Psychosocial factors in noncompliance during liver transplant selection.

Authors:  R G Harper; J Wager; R C Chacko
Journal:  J Clin Psychol Med Settings       Date:  2010-03

Review 4.  Substance use disorders before and after liver transplantation.

Authors:  Jason L Eccleston; Michael R Lucey
Journal:  Clin Liver Dis (Hoboken)       Date:  2017-10-31

Review 5.  Long-term survival after liver transplantation for alcoholic liver disease.

Authors:  Paula Iruzubieta; Javier Crespo; Emilio Fábrega
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

6.  Alcohol-Associated Liver Disease Before and After COVID-19-An Overview and Call for Ongoing Investigation.

Authors:  Andrew M Moon; Brenda Curtis; Pranoti Mandrekar; Ashwani K Singal; Elizabeth C Verna; Oren K Fix
Journal:  Hepatol Commun       Date:  2021-06-05

7.  Tobacco Use is a Modifiable Risk Factor for Post-Transplant Biliary Complications.

Authors:  David T Dulaney; Katherine M Dokus; Scott McIntosh; Bandar Al-Judaibi; Gopal A Ramaraju; Koji Tomiyama; Mark Levstik; Roberto Hernandez-Alejandro; Mark S Orloff; Randeep Kashyap
Journal:  J Gastrointest Surg       Date:  2017-08-07       Impact factor: 3.452

8.  Management of the Cirrhotic Patient Before Liver Transplantation: The Role of the Referring Gastroenterologist.

Authors:  R Todd Stravitz
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-05

Review 9.  Incidence, risk factors and outcome of de novo tumors in liver transplant recipients focusing on alcoholic cirrhosis.

Authors:  Carlos Jiménez-Romero; Iago Justo-Alonso; Félix Cambra-Molero; Jorge Calvo-Pulido; Álvaro García-Sesma; Manuel Abradelo-Usera; Oscar Caso-Maestro; Alejandro Manrique-Municio
Journal:  World J Hepatol       Date:  2015-05-08

Review 10.  Liver Transplantation for Alcohol-Related Liver Disease.

Authors:  Narendra S Choudhary; Naveen Kumar; Sanjiv Saigal; Rahul Rai; Neeraj Saraf; Arvinder S Soin
Journal:  J Clin Exp Hepatol       Date:  2016-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.